Median Technologies SA (EPA:ALMDT)

France flag France · Delayed Price · Currency is EUR
4.855
-0.315 (-6.09%)
At close: Feb 27, 2026
78.49%
Market Cap 179.24M
Revenue (ttm) 23.38M
Net Income (ttm) -21.99M
Shares Out 36.92M
EPS (ttm) -1.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 611,771
Average Volume 856,783
Open 5.210
Previous Close 5.170
Day's Range 4.800 - 5.350
52-Week Range 1.192 - 7.270
Beta 0.50
RSI 49.25
Earnings Date Apr 23, 2026

About Median Technologies

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imagin... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 211
Stock Exchange Euronext Paris
Ticker Symbol ALMDT
Full Company Profile

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.

Financial Statements

News

There is no news available yet.